版權所有 © 2014 臺灣大學藥學專業學院
100025 臺北市林森南路33號
電話 : (02)3366-8750~4 (共五線) 傳真 : (02)2391-9098
網頁負責人: 許瑭益
聯絡電話 : (02)33668743
更新日期 : 2024 / 11 / 26
隱私權及資訊安全政策
|
|
|
|
|
|
| |
已發表論文 | : | | | 書籍 | : | 書名:特定標的之新藥開發: 第九章 臨床前藥物動力學試驗 (2005) 作者:林君榮
| 展演 | : | 展演主題:Enhancement of dissolution rate and oral bioavailability of lovastatin in red yeast rice products (2014) 講者:Chia-Hao Chen, Jyh-Chin Yang, Yow-Shieng Uang, Chun-Jung Lin 地點:5th FIP Pharmaceutical Sciences World Congress (PWSC), Melbourne, Australia
展演主題:The interaction between human PMAT and N-methyl-(R)SAL/1-benzyl-TIQ (2013) 講者:Kuo-Chen Wu, Yi-Hsuan Peng, Ya-Hsuan Lu, Chun-Jung Lin 地點:The 11th International Conference On Alzheimer’s & Parkinson’s Disease. Firenze, Italy
展演主題:Pharmacokinetic/pharmacodynamic analysis of the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter Pylori (2012) 講者:Yu-Fan Yang, Jyh-Chin Yang, Yow-Shieng Uang, Chun-Jung Lin 地點:World Conference on Pharmacometrics, Seoul, Korea
展演主題:The effects of Chinese red yeast rice on the activities of CYP450 enzymes and P-glycoprotein and the pharmacokinetic study of LipoCol Forte® in healthy volunteers. (2011) 講者:Chia-Hao Chen, Jyh-Chin Yang, Yow-Shieng Uang, Shang-Ta Wang, Chun-Jung Lin 地點:AAPS annual meeting at Walter E. Washington Convention Center, Washington, DC, USA
展演主題:The PKC-mediated down-regulation of P-glycoprotein expression under high glucose condition in MDCK II cells (2011) 講者:Szu-Yu Yeh, Chung-Cheng Lin, Chun-Jung Lin 地點:Bethesda AAPS (American Association of Pharmaceutical Scientists) Workshop, Bethesda North Marriott Conference Center, Bethesda, MD, USA.
展演主題:High Cumulative Eradication rate in the First-line and Rescue therapy for Helicobacter pylori infection by Repeated High dose dual therapy (2015) 講者:Jyh-Chin Yang, Chun-Jung Lin, Jin-De Chen et al. 地點:Digestive Disease Week (DDW), Washington, D.C. 20001, United States
展演主題:Effect of lipopolysaccharide on the expression of plasma membrane monoamine transporter (PMAT) at brain microvessels and the brain concentrations of 1-benzyl-1, 2, 3, 4-tetrahydroisoquinoline in C57BL/6 mice (2015) 講者:Kuo-Chen Wu, Ya-Hsuan Lu, Chun-Jung Lin 地點:7th Asian Association of School of Pharmacy (AASP) meeting, Taipei, Taiwan
展演主題:Increased P-glycoprotein expression in brain capillaries of Huntington’s disease transgenic mice and patients. (2016) 講者:Kao YH, Chern Y, Yang HT, Chen HM, Lin CJ 地點:11th Annual Huntington\'s disease therapeutics conference Palm Springs, CA, USA
展演主題:Genotypic testing is suboptimal to predict antibiotic resistance and therapeutic outcome for Helicobacter pylori eradication in clinical practice (2016) 講者:Jyh-Chin Yang, Chun-Jung Lin, Huei-Mi Li et al. 地點:Digestive Disease Week (DDW) San Diego, California, USA
展演主題:Changes in the pharmacokinetics of fluvastatin, atorvastatin, and simvastatin but not of rosuvastatin and pravastatin in collagen-induced arthritis rats (2017) 講者:Chun-Han Lin, Ke-Wei Hsu, Chia-Hao Chen, Yow-Shieng Uang, Chun-Jung Lin 地點:6th FIP Pharmaceutical Sciences World Congress (PSWC) Stockholm, Sweden
展演主題:Brain homeostasis of α-synuclein differs in mice with and without functional Nramp1 under PD-related pathological conditions (2018) 講者:Kuo-Chen Wu, Chun-Jung Lin 地點:International conference on Alzheimer’s disease & Dementia, Tokyo, Japan
展演主題:The role of equilibrative nucleoside transporter-2 in the modulation of neuroinflammation (2018) 講者:Chih-Yu Lee, Kuo-Chen Wu, Yu-Han Kao, Chun-Jung Lin 地點:2018 Society for Neurosciences annual meeting, San Diego, USA
展演主題:The role of equilibrative nucleoside transporter-2 on the amelioration of acute lipopolysaccharide-induced breakdown of the blood-brain barrier (2019) 講者:Kuo-Chen Wu, Chun-Jung Lin 地點:Brain & brain PET 2019 (Yokohama, Japan)
展演主題:Roles of equilibrative nucleoside transporter-2 in energy homeostasis in the striatum of mice (2022) 講者:C.-J. HO1, C.-Y. CHEN1, K.-C. WU1, Y. CHERN2, C.-J. LIN 地點:SfN (USA)
展演主題:Inhibition of equilibrative nucleoside transporter 1 (ENT1) inhibitor as a novel therapeutic treatment to rescue Alzheimer’s disease pathology and cognitive impairment (2022) 講者:Ching-Wen Wu, Ching-Pang Chang, Chien-Yu Lin, Kuo-Chen Wu, Hsin-Hsien Yeh, Chun-Jung Lin, Yijuang Chern 地點:CTAD (USA)
| 研究計畫 | : | 計畫名稱:探討腺苷轉運蛋白在缺血性中風以及缺血-再灌流所引起之病理反應與疾 病進展所扮演之角色 執行期間:2021-08 ~ 2024-07 主持人:林君榮
計畫名稱:通過改善腦能量流失來治療阿茲海默症 執行期間:2021-01 ~ 2024-12 主持人:陳儀莊 協同主持人:林君榮
計畫名稱:探討腦部核苷平衡在巴金森氏症之發病機制及治療上所扮演的角色 執行期間:2020-08 ~ 2021-07 主持人:林君榮
計畫名稱:研究平衡核苷轉運蛋白在神經發炎的生理及病理角色-以亨丁頓舞蹈症為疾病模型- ENT2 對神經發炎之調控以及其對亨丁頓舞蹈症之疾病進展的影響 執行期間:2018-08 ~ 2021-07 主持人:林君榮
計畫名稱:風濕性關節炎及非類固醇消炎劑治療對血腦屏障之調控以及其對於beta類澱粉蛋 白(beta-amyloid)在血腦屏障運輸之影響( 執行期間:2017-08 ~ 2020-07 主持人:林君榮
計畫名稱:探討神經元與星狀細胞在調控亨丁頓舞蹈症腦內腺嘌呤核苷酸所扮演之角色 執行期間:2017-01 ~ 2017-12 主持人:林君榮
計畫名稱:探討 SLC11A1轉運蛋白在 alpha-synuclein 降解所扮演的角色以及其對於 alpha-synuclein 所引起神經毒性之影響 執行期間:2016-08 ~ 2017-07 主持人:林君榮
計畫名稱:類風性關節炎對於CYP450酵素以及轉運蛋白表現之影響以及其對於statins藥物之藥動學性質影響研究 執行期間:2015-08 ~ 2016-07 主持人:林君榮
計畫名稱:以腦內腺苷濃度作為治療漢丁頓舞蹈症之標的 執行期間:2015-01 ~ 2015-12 主持人:林君榮
計畫名稱:具神經保護作用之雙功能腺苷衍生物在神經退化疾病上的研發─(子計畫二)神經退化疾病對腺苷衍生物穿透血腦屏障影響之研究 執行期間:2011-05 ~ 2014-04 主持人:林君榮
|
|
|
|
|